Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial. Li J, Hou L, Guo X, Jin P, et al. Nat Med 2022 Jan 27. pii: 10.1038/s41591-021-01677.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li J, Hou L, Guo X, Jin P, et al. Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial. Nat Med 2022 Jan 27. pii: 10.1038/s41591-021-01677.
PMID: 35087233